索信達(03680.HK)成功研發風險管理類解決方案平臺
索信達控股(03680.HK)公佈,在風險管理解決方案的研發取得新進展,成功研發風險管理類解決方案平臺—靈矩全景式監管合規平臺,爲金融機構提供監管合規整體解決方案。集團指該平臺是其在風險管理領域,繼實時欺詐偵測、信貸評估和內部風險管理的又一重要突破。
集團指,爲滿足金融機構面向中國人民銀行、中國銀行保險監督管理委員會、國家外匯管理局等金融監管機構的監管報送要求,該平臺已率先在某國有銀行中得到實踐驗證。董事會認爲,該平臺便於滿足金融機構面向金融監管機構的監管報送要求,提升其監管數據治理與建設能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.